TRS-005

고객리뷰

Based on 1 Customer Validation

TRS-005 is an anti-CD20 ADC, formed by conjugating an anti-CD20 monoclonal antibody to MMAE (HY-15162) via a Val-Cit (HY-140014) linker. TRS-005 targets CD20-positive tumor cells and delivers MMAE into cells through receptor-mediated endocytosis. TRS-005 can be used for research on relapsed/refractory B-cell non-Hodgkin lymphoma (specifically diffuse large B-cell lymphoma).

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

  • Purity: 99.83%
  • 보관:

    -80°C, protect from light

  • Biological Activity
  • Chemical Information
  • 순도&문서
  • References
  • Help & FAQs
100 mg

견적 받기 해외재고보유

Please select quantity
Amount: USD 0.00